Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAI + Chemotherapy vs Chemotherapy in Unresectable CRLM
NCT03125161Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Apr 2017
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Colorectal cancer with liver metastases (CRLM) (2 arms), sponsored by Fudan University. Primary endpoints: Conversional Resection Rates and Survival. Status: unknown.
02
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03125161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03125161.